Prosthetic Joint Infection Market is Anticipated to Witness Significant Growth Owing to Rising Cases of Arthritis
Prosthetic Joint Infection Market is Anticipated to Witness Significant Growth Owing to Rising Cases of Arthritis
Blog Article
The prosthetic joint infection market comprises products such as antibiotics and antiseptic components that are used to prevent and treat infections in prosthetic joints. Demand for prosthetic joints is increasing rapidly due to the rising prevalence of osteoarthritis and other joint disorders globally. According to statistical estimates, over 300 million people suffer from osteoarthritis worldwide. Furthermore, prolonged life expectancy has also contributed to the growing geriatric population who are more prone to joint disorders such as arthritis.
The prosthetic joint infection market is estimated to be valued at USD 64.2 Mn in 2024 and is expected to reach USD 91.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Key Takeaways
Key players operating in the prosthetic joint infection market are Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG.
The rising cases of prosthetic joint replacement surgeries worldwide present significant growth opportunities in the Prosthetic Joint Infection Market. According to estimates, over one million knee and hip replacement surgeries are performed in the United States annually. Furthermore, increasing healthcare expenditures in developing nations are also anticipated to drive the volume of joint replacement procedures in the coming years.
North America dominated the global prosthetic joint infection market in 2018. However, the Asia Pacific region is estimated to offer lucrative expansion opportunities during the forecast period owing to growing medical tourism, rising healthcare expenditures, and increasing focus of market players.
Market Drivers
- Growing geriatric population prone to joint disorders - The rapidly aging global population especially in developed economies lowers immunity and increases the risk of arthritis and prosthetic joint infections.
- Increasing joint replacement surgeries - Surging cases of osteoarthritis and trauma injuries have boosted the volume of knee and hip replacement surgeries globally. This expands the installed base of prosthetic joints at risk of infections.
Market Restraints
- High cost of treatment - Treatment of prosthetic joint infections involves multiple revision surgeries and prolonged use of intravenous or oral antibiotics which adds to the overall healthcare burden.
- Misdiagnosis - Symptoms of prosthetic joint infections often mimic other conditions like soreness from implant wear, delaying accurate diagnosis and effective treatment.
Segment Analysis
The prosthetic joint infection market can be segmented based on implant type, causative organism, treatment and geography. Based on implant type, the global prosthetic joint infection market can be segmented into hip, knee, shoulder and others. The hip implant segment currently dominates the market due to the rising number of hip replacement procedures performed globally.
Based on causative organism, the market can be categorized into gram positive cocci, gram negative cocci and others. Gram positive cocci accounts for the largest share as they are the most common cause of prosthetic joint infections. Based on treatment, the market is segmented into antibiotics and surgery. Antibiotic treatment holds a major share as it is the first line of treatment for prosthetic joint infections.
Global Analysis
Regionally, North America holds the largest share in the global prosthetic joint infection market due to favorable reimbursement policies and new product innovations. Europe accounts for the second largest share. However, Asia Pacific region is expected to witness the highest growth rate during the forecast period owing to increasing healthcare expenditure and rising medical tourism in countries like India and China. Within Asia Pacific region, China dominates the market due to large population base and growing geriatric population. Growing number of joint replacement procedures, rising prevalence of osteoarthritis and diabetic foot infections are some of the key factors driving the demand for prevention and treatment of prosthetic joint infections globally.
Get more insights on: Prosthetic Joint Infection Market
Author Bio:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )